potential of drug interactions among hospitalized cancer patients in a developing country

Authors

maria tavakoli ardakani 1- department of clinical pharmacy, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. 2- pharmaceutical sciences research center, shahid beheshti university of medical sciences, tehran, iran.

kaveh kazemian 1- department of clinical pharmacy, school of pharmacy, mazandaran university of medical sciences, sari, iran. 2- students research committee, shahid beheshti university of medical sciences, tehran, iran.

jamshid salamzadeh department of clinical pharmacy, school of pharmacy, mazandaran university of medical sciences, sari, iran.

mahshid mehdizadeh bone marrow transplantion center, taleghani hospital,shahid beheshti university of medical sciences, tehran, iran.

abstract

cancer patients are more susceptible to adverse drug-drug interactions (ddis) due to receiving multiple medications especially chemotherapy medications, hormonal agents and supportive care drugs. the aim of this study is to describe the prevalence of potential ddis and to identify risk factors for these potential interactions in hospitalized cancer patients in a developing country.a cross-sectional study conducted by reviewing charts of 224 consecutive in hospitalized patients in hematology-oncology ward of a teaching hospital in tehran, during a 12 month period from july 2009 to july 2010. “drug interaction facts 2008, 2009: the authority on drug interactions” was used for screening the potential drug-drug interactions. potential interactions were classified by levels of severity and documentation.the median age of patients was 50 years, the length of hospital stay for patient was 5 days and the number of drugs per patient was 8 drugs. two hundred and twenty-eight potential interactions were detected. nearly 14% of the interactions were major and 60% were moderate. approximately 9% and 10% potential interactions were graded as established and probable. in multivariate analysis, being older than 61 years old, suffering from hematologic cancer, source of cancer in different specific organs (esophagus, testis and cervices more than other sources), and number of ordered drugs for patients were independent predictors of having at least one potential ddi in hospital order. suffering from hematologic cancer, source of cancer in different organs, length of hospital stay and number of ordered drugs for patients were independent predictors for number of interactions per patients.having a ddi seems to be more likely to occur in patients older than 61 years old. hematologic cancers, having more medications in physician’s order, longer length of hospital stay, esophageal cancer, testicular cancer and cervical cancer have related to having a ddi and also having more number of interactions.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country

Cancer patients are more susceptible to adverse drug-drug interactions (DDIs) due to receiving multiple medications especially chemotherapy medications, hormonal agents and supportive care drugs. The aim of this study is to describe the prevalence of potential DDIs and to identify risk factors for these potential interactions in hospitalized cancer patients in a developing country.A cross-secti...

full text

Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country

Cancer patients are more susceptible to adverse drug-drug interactions (DDIs) due to receiving multiple medications especially chemotherapy medications, hormonal agents and supportive care drugs. The aim of this study is to describe the prevalence of potential DDIs and to identify risk factors for these potential interactions in hospitalized cancer patients in a developing country.A cross-secti...

full text

Potential drug-drug interactions among hospitalized patients in a developing country

Background: Drug-drug interactions (DDIs) may often lead to preventable adverse drug events and health damage. Particularly in hospitals, this might be an important factor as multiple drug therapies are common. The objective of this study was to identify the frequency and levels of potential DDIs in internal medicine wards in an Iranian university hospital. Methods: A cross-sectional study...

full text

Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country

Cancer patients are more susceptible to adverse drug-drug interactions (DDIs) due to receiving multiple medications especially chemotherapy medications, hormonal agents and supportive care drugs. The aim of this study is to describe the prevalence of potential DDIs and to identify risk factors for these potential interactions in hospitalized cancer patients in a developing country. A cross-sect...

full text

incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country

the objective of this study was to determine incidence rate, type, and pattern of clinically relevant potential drug-drug interactions (pddis) in a large outpatient population of a developing country. a retrospective, descriptive cross-sectional study was conducted on outpatients’ prescriptions in khorasan razavi province, iran, over 12 months. a list of 25 clinically relevant ddis, which are l...

full text

Prevalence of Potential Drug-Drug Interactions in Hospitalized Surgical Patients

The objective of this study is to estimate the prevalence and describe the characteristics of pDDIs (potential drug-drug interactions) in medical prescriptions of hospitalized surgical patients. In this cross-sectional study, we analyzed 370 medical prescriptions from the surgery unit of a Mexican public teaching hospital. The identification and classification of potential drug-drug interaction...

full text

My Resources

Save resource for easier access later


Journal title:
the iranian journal of pharmaceutical research

جلد ۱۲، شماره Supplement، صفحات ۱۷۵-۱۸۲

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023